Page last updated: 2024-10-23

azathioprine and Uveal Diseases

azathioprine has been researched along with Uveal Diseases in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Uveal Diseases: Diseases of the uvea.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lavina, AM1
Agarwal, A1
Hunyor, A1
Gass, JD1
Spees, EK1
Kramer, KK1
Light, JA1
Oakes, DD1
Zimmerman, LE1

Other Studies

2 other studies available for azathioprine and Uveal Diseases

ArticleYear
Lupus choroidopathy and choroidal effusions.
    Retina (Philadelphia, Pa.), 2002, Volume: 22, Issue:5

    Topics: Adult; Antirheumatic Agents; Azathioprine; Choroid Diseases; Ciliary Body; Drug Therapy, Combination

2002
Reactivation of ocular malignant melanoma after renal transplantation.
    Transplantation, 1980, Volume: 29, Issue:5

    Topics: Adult; Antilymphocyte Serum; Azathioprine; Eye Neoplasms; Female; Humans; Immunosuppressive Agents;

1980